anti-CTLA4 antibody (Abzena)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameanti-CTLA4 antibody (Abzena)
Drug Alias NameCTLA-4 checkpoint inhibitor (Antitope)anti-CTLA4 antibody (Antitope)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionCytotoxic T-Lymphocyte-Associated Antigen 4 inhibitors
TargetsCytotoxic T-Lymphocyte-Associated Antigen 4
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAntitope
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbzena LtdAntitope
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A